🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate and compare the effects of Alendronate and Risedr...
Status
Completed
Location
Multiple Locations
Start Date
2002-09-01
Trial ID
NCT00092014
The purpose of this study is to identify the best way to prevent bone loss ...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2015-02-01
Trial ID
NCT02186600
Treatments Being Tested
This is a randomized, open-label, multi-center, 4-treatment, 4-period cross...
Status
Completed
Location
Research Site
Start Date
2007-11
Trial ID
NCT00755872
Treatments Being Tested
Can risedronate given once weekly for 6 months prevent periprosthetic bone ...
Status
Completed
Location
Orthopaedic department, Danderyd Hospital
Start Date
2006-04
Trial ID
NCT00772395
Treatments Being Tested
This is a 2-year study to evaluate the effect of denosumab versus risedrona...
Status
Completed
Location
Research Site
Start Date
2012-03-28
Trial ID
NCT01575873
Treatments Being Tested
Aromatase inhibitor therapy is in France the adjuvant reference treatment f...
Status
Completed
Location
Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot
Start Date
2009-11
Trial ID
NCT00859703
Treatments Being Tested
The purpose of this study is to find out if Risedronate works to prevent os...
Status
Completed
Location
Hamilton Health Sciences, Chedoke Site
Start Date
2000-02
Trial ID
NCT00150696
Treatments Being Tested
To confirm the non-inferiority of 75 mg risedronate tablets taken on 2 cons...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-07
Trial ID
NCT00358176
Treatments Being Tested
The study hypothesis is that nutritional supplementation together with bisp...
Status
Completed
Location
Department of Geriatric Medicine R94, Karolinska University Hospital
Start Date
2004-12
Trial ID
NCT01950169
Treatments Being Tested
The objective of this study is to test the hypothesis that teriparatide is ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-07
Trial ID
NCT00503399
Treatments Being Tested